Overview

A Study to Evaluate the Bioequivalence of Single Oral Dose of Esomeprazole Capsule and Tablet Formulation in Healthy Participants

Status:
Completed
Trial end date:
2017-05-13
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the bioequivalence of esomeprazole 40 milligram (mg) tablets and capsules.
Phase:
Phase 1
Details
Lead Sponsor:
Takeda
Treatments:
Esomeprazole